Cerebral infarction developing in a patient without cancer with a markedly elevated level of mucinous tumor marker.

Yamashiro, Kazuo; Furuya, Tsuyoshi; Noda, Kazuyuki; Urabe, Takao; Hattori, Nobutaka; Okuma, Yasuyuki

Yamashiro, Kazuo; Furuya, Tsuyoshi; Noda, Kazuyuki; Urabe, Takao; Hattori, Nobutaka; Okuma, Yasuyuki.

Affiliation

Yamashiro K; Department of Neurology, Juntendo University Shizuoka Hospital, Shizuoka, Japan. kazuo-y@juntendo.ac.jp

J Stroke Cerebrovasc Dis ; 21(7): 619.e1-2, 2012 Oct.

Article in En | MEDLINE | ID: mdl-21277226

Subject(s)

Adenomyosis/complications; CA-125 Antigen/blood; Cerebral Infarction/etiology; Frontal Lobe/blood supply; Parietal Lobe/blood supply; Adenomyosis/blood; Adenomyosis/diagnosis; Adenomyosis/drug therapy; Adult; Aphasia, Broca/etiology; Cerebral Infarction/blood; Cerebral Infarction/diagnosis; Female; Fibrin Fibrinogen Degradation Products/metabolism; Humans; Magnetic Resonance Imaging; Predictive Value of Tests; Treatment Outcome; Up-Regulation

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Parietal Lobe / Cerebral Infarction / CA-125 Antigen / Adenomyosis / Frontal Lobe Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Adult / Female / Humans Language: En Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google